Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S4 from The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma
  1. Home
  2. Publications
  3. Supplementary Table S4 from The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma

Supplementary Table S4 from The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma

Authors:
  • NPNavin Pinto
    Navin Pinto
  • AKAnnette Künkele
    Annette Künkele
  • CACatherine M. Albert
    Catherine M. Albert
  • MTMallory R. Taylor
    Mallory R. Taylor
  • HUHeidi B. Ullom
    Heidi B. Ullom
  • NVNicholas A. Vitanza
    Nicholas A. Vitanza
  • AWAshley L. Wilson
    Ashley L. Wilson
  • BCBonnie L. Cole
    Bonnie L. Cole
  • CYCecilia C.S. Yeung
    Cecilia C.S. Yeung
  • JWJocelyn H. Wright
    Jocelyn H. Wright
  • WHWenjun Huang
    Wenjun Huang
  • JWJason Wendler
    Jason Wendler

Open Access
Publisher website
Google Scholar
  • 15 September 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33775939
Abstract
Supplementary Table S4 – Toxicities Possibly, Probably or Definitely Related to First Infusion of CAR T Cells.
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
  • PEDIATRIC CANCERS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.